Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Glenmark Pharmaceuticals (GNP IN)
Watchlist
126
Analysis
Health Care
•
India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
25 Apr 2024 20:42
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Credit Rating
Attachment
Exchange Announcement •
12 Apr 2024 18:40
GLENMARK PHARMACEUTICALS LTD. - 532296 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Attachment
Exchange Announcement •
12 Apr 2024 18:29
GLENMARK PHARMACEUTICALS LTD. - 532296 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Attachment
Exchange Announcement •
11 Apr 2024 18:41
GLENMARK PHARMACEUTICALS LTD. - 532296 - Certificate From Practicing Company Secretary Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024
Attachment
Exchange Announcement •
02 Apr 2024 20:10
GLENMARK PHARMACEUTICALS LTD. - 532296 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x